Lv11
30 积分 2024-09-30 加入
The Neutrophil Life Cycle
1小时前
已完结
A Small-Molecule Inhibitor to the Cytokine Interleukin-4
20天前
已完结
The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD
24天前
已完结
Allosteric CDC37 inhibitor disrupts chaperone complex to block CDK4/6 maturation
28天前
已完结
Are all the IL-23 blockers the same in inflammatory bowel disease?
1个月前
已完结
Trends in GPCR drug discovery: new agents, targets and indications
1个月前
已完结
Update on Type 2 Immunity
1个月前
已完结
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma
1个月前
已完结
AI has dreamt up a blizzard of new proteins. Do any of them actually work?
1个月前
已完结
Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
2个月前
已完结
皖公网安备34019202002308
